Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 288(8): 5257-67, 2013 Feb 22.
Article in English | MEDLINE | ID: mdl-23288843

ABSTRACT

The signaling cascades mediated by G protein-coupled receptors (GPCRs) exhibit a wide spectrum of spatial and temporal response properties to fulfill diverse physiological demands. However, the mechanisms that shape the signaling response of the GPCR are not well understood. In this study, we replaced cone transducin α (cTα) for rod transducin α (rTα) in rod photoreceptors of transgenic mice, which also express S opsin, to evaluate the role of Gα subtype on signal amplification from different GPCRs in the same cell; such analysis may explain functional differences between retinal rod and cone photoreceptors. We showed that ectopically expressed cTα 1) forms a heterotrimeric complex with rod Gß(1)γ(1), 2) substitutes equally for rTα in generating photoresponses initiated by either rhodopsin or S-cone opsin, and 3) exhibited similar light-activated translocation as endogenous rTα in rods and endogenous cTα in cones. Thus, rTα and cTα appear functionally interchangeable. Interestingly, light sensitivity appeared to correlate with the concentration of cTα when expression is reduced below 35% of normal. However, quantification of endogenous cTα concentration in cones showed a higher level to rTα in rods. Thus, reduced sensitivity in cones cannot be explained by reduced coupling efficiency between the GPCR and G protein or a lower concentration of G protein in cones versus rods.


Subject(s)
GTP-Binding Protein beta Subunits/metabolism , GTP-Binding Protein gamma Subunits/metabolism , Gene Expression Regulation , Retinal Cone Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/metabolism , Transducin/physiology , Animals , DNA, Complementary/metabolism , Female , GTP-Binding Proteins/metabolism , Light , Light Signal Transduction , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Models, Biological , Opsins/metabolism , Pigmentation , Receptors, G-Protein-Coupled/metabolism , Retina/metabolism , Retinal Cone Photoreceptor Cells/cytology , Retinal Rod Photoreceptor Cells/cytology , Rhodopsin/metabolism , Signal Transduction , Transducin/genetics
2.
J Alzheimers Dis ; 8(3): 227-41, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16340081

ABSTRACT

Increasing evidence suggests that oxidative injury is involved in the pathogenesis of many age-related neurodegenerative disorders, including Alzheimer's disease (AD). Identifying the protein targets of oxidative stress is critical to determine which proteins may be responsible for the neuronal impairments and subsequent cell death that occurs in AD. In this study, we have applied a high-throughput shotgun proteomic approach to identify the targets of protein carbonylation in both aged and PS1 + AbetaPP transgenic mice. However, because of the inherent difficulties associated with proteomic database searching algorithms, several newly developed bioinformatic tools were implemented to ascertain a probability-based discernment between correct protein assignments and false identifications to improve the accuracy of protein identification. Assigning a probability to each identified peptide/protein allows one to objectively monitor the expression and relative abundance of particular proteins from diverse samples, including tissue from transgenic mice of mixed genetic backgrounds. This robust bioinformatic approach also permits the comparison of proteomic data generated by different laboratories since it is instrument- and database-independent. Applying these statistical models to our initial studies, we detected a total of 117 oxidatively modified (carbonylated) proteins, 59 of which were specifically associated with PS1 + AbetaPP mice. Pathways and network component analyses suggest that there are three major protein networks that could be potentially altered in PS1 + AbetaPP mice as a result of oxidative modifications. These pathways are 1) iNOS-integrin signaling pathway, 2) CRE/CBP transcription regulation and 3) rab-lyst vesicular trafficking. We believe the results of these studies will help establish an initial AD database of oxidatively modified proteins and provide a foundation for the design of future hypothesis driven research in the areas of aging and neurodegeneration.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Protein Precursor/metabolism , Disease Models, Animal , Membrane Proteins/metabolism , Oxidative Stress/physiology , Proteomics/methods , Synaptic Membranes/metabolism , Activating Transcription Factor 2/metabolism , Aging/physiology , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Animals , Cell Death , Integrins/metabolism , Mice , Mice, Transgenic , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Nerve Net/physiology , Nitric Oxide Synthase/metabolism , Phosphoproteins/metabolism , Presenilin-1 , Probability , Protein Carbonylation/physiology , Signal Transduction/physiology , Synaptic Membranes/pathology
3.
J Neurochem ; 92(4): 705-17, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15686472

ABSTRACT

Abstract Oxidative stress imparted by reactive oxygen species (ROS) is implicated in the pathogenesis of Alzheimer's disease (AD). Given that amyloid beta (Abeta) itself generates ROS that can directly damage proteins, elucidating the functional consequences of protein oxidation can enhance our understanding of the process of Abeta-mediated neurodegeneration. In this study, we employed a biocytin hydrazide/streptavidin affinity purification methodology followed by two-dimensional liquid chromatography tandem mass spectrometry coupled with SEQUEST bioinformatics technology, to identify the targets of Abeta-induced oxidative stress in cultured primary cortical mouse neurons. The Golgi-resident enzyme glucuronyltransferase (GlcAT-P) was a carbonylated target that we investigated further owing to its involvement in the biosynthesis of HNK-1, a carbohydrate epitope expressed on cell adhesion molecules and implicated in modulating the effectiveness of synaptic transmission in the brain. We found that increasing amounts of Abeta, added exogenously to the culture media of primary cortical neurons, significantly decreased HNK-1 expression. Moreover, in vivo, HNK-1 immunoreactivity was decreased in brain tissue of a transgenic mouse model of AD. We conclude that a potential consequence of Abeta-mediated oxidation of GlcAT-P is impairment of its enzymatic function, thereby disrupting HNK-1 biosynthesis and possibly adversely affecting synaptic plasticity. Considering that AD is partly characterized by progressive memory impairment and disordered cognitive function, the data from our in vitro studies can be reconciled with results from in vivo studies that have demonstrated that HNK-1 modulates synaptic plasticity and is critically involved in memory consolidation.


Subject(s)
Amyloid beta-Peptides/pharmacology , CD57 Antigens/metabolism , Down-Regulation , Neural Cell Adhesion Molecules/biosynthesis , Oxidative Stress/physiology , Peptide Fragments/pharmacology , Proteomics , Synaptic Transmission/physiology , Amino Acid Sequence , Amyloid beta-Peptides/genetics , Animals , CD57 Antigens/biosynthesis , Carbohydrate Conformation , Carbohydrate Sequence , Cells, Cultured , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Glucuronosyltransferase/isolation & purification , Glucuronosyltransferase/metabolism , Mice , Mice, Transgenic , Molecular Sequence Data , Neural Cell Adhesion Molecules/antagonists & inhibitors , Neurons/drug effects , Neurons/enzymology , Oxidative Stress/drug effects , Peptide Fragments/genetics , Pregnancy , Proteomics/methods , Synaptic Transmission/drug effects
4.
Pharm Res ; 21(7): 1094-102, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15290847

ABSTRACT

PURPOSE: Amyloid-beta (Abeta) is a self-aggregating protein found in senile plaques in Alzheimer's disease (AD) brain and is thought to play a major role in the disease process. Oxidative stress may be a predominant cause of the formation of these Abeta aggregates. This study aims at identifying possible sites of copper-catalyzed oxidation of Abeta1-40 using liquid chromatography tandem mass spectrometry (LC/MS/MS) and scoring algorithm for spectral analysis (SALSA). Traditionally, identification of post-translational modifications by tandem mass spectrometric analysis requires users to inspect manually thousands of MS/MS spectra, which can be a tedious and time-consuming process. With the use of SALSA, users can automatically search for post-translational modifications based on the spacing of the m/z values associated with the ion series of an amino acid sequence. METHODS: Abeta1-40 was subjected to copper-catalyzed oxidative stress. LC/MS/MS and SALSA analyses were used to determine the sites of post-translational modification within the tryptic fragments. RESULTS: Oxidation was found to occur preferentially at the histidine residues Hisl3 and Hisl4 and at the methionine residue (Met35) of Abeta1-40. CONCLUSIONS: The combination of LC/MS/MS and SALSA searches could dramatically improve the efficiency and accuracy of determining the specific sites of oxidation of in vitro, copper-oxidized Abeta1-40 as well as other oxidized proteins.


Subject(s)
Algorithms , Amyloid beta-Peptides/chemistry , Peptide Fragments/chemistry , Amyloid beta-Peptides/chemical synthesis , Catalysis , Chromatography, Liquid/methods , Copper , Mass Spectrometry/methods , Oxidation-Reduction , Peptide Fragments/chemical synthesis
5.
Pharm Res ; 20(11): 1713-20, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14661913

ABSTRACT

PURPOSE: The major initiative of this study was to implement a novel proteomic approach in order to detect protein carbonylation in aged mouse brain. Several lines of evidence indicate that reactive oxygen species (ROS)-induced protein oxidation plays an essential role in the initiation of age-related neuropathologies. Therefore, the identification of free radical or peroxide substrates would provide further insight into key biochemical mechanisms that contribute to the progression of certain neurological disorders. METHODS: Historically, ROS targets have been identified by conventional immunological two-dimensional (2-D) gel electrophoresis and mass spectrometric analyses. However, specific classes of proteins, such as transmembrane-spanning proteins, high-molecular-weight proteins, and very acidic or basic proteins, are frequently excluded or underrepresented by these analyses. In order to fill this technologic gap, we have used a functional proteomics approach using a liquid chromatography tandem mass spectrometric (LC-MS/MS) analysis coupled with a hydrazide biotin-streptavidin methodology in order to identify protein carbonylation in aged mice. RESULTS: Our initial studies suggest an ability to identify at least 100 carbonylated proteins in a single LC-MS/MS experiment. In addition to high-abundance cytosolic proteins that have been previously identified by 2-D gel electrophoresis and mass spectrometric analyses, we are able to identify several low-abundance receptor proteins, mitochondrial proteins involved in glucose and energy metabolism, as well as a series of receptors and tyrosine phosphatases known to be associated with insulin and insulin-like growth factor metabolism and cell-signaling pathways. CONCLUSIONS: Here we describe a rapid and sensitive proteomic analysis for the identification of carbonylated proteins in mouse brain homogenates through the conjunction of liquid chromatography and tandem mass spectrometry methods. We believe the ability to detect these post-translationally modified proteins specifically associated with brain impairments during the course of aging should allow one to more closely and objectively monitor the efficacy of various clinical treatments. In addition, the discovery of these unique brain biomarkers could also provide a conceptual framework for the future design of alternative drugs in the treatment of a variety of age-related neurodegenerative disorders.


Subject(s)
Brain/metabolism , Nerve Tissue Proteins/metabolism , Oxidative Stress/physiology , Protein Processing, Post-Translational , Proteomics/methods , Aging/metabolism , Animals , Gas Chromatography-Mass Spectrometry/methods , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/analysis , Reactive Oxygen Species/analysis , Reactive Oxygen Species/metabolism , Sensitivity and Specificity
6.
Adv Drug Deliv Rev ; 55(11): 1515-24, 2003 Nov 14.
Article in English | MEDLINE | ID: mdl-14597144

ABSTRACT

Alterations in the trafficking and function of the endocytic pathway have been extensively documented to be one of the earliest pathological changes in sporadic Alzheimer's disease (AD). Although the pathophysiological consequences of these endosomal/lysosomal changes are currently unknown, several recent studies have suggested that such changes in endocytic function are able to cause a redistribution of several lysosomal hydrolases into early endosomes, leading to the overproduction of neurotoxic amyloid peptide. Recently, we and others have demonstrated that abnormal endocytic pathology within post-mitotic neurons can, in part, be attributed to alterations in sphingomyelin/ceramide metabolism, resulting in the intracellular accumulation of ceramide. Once inside the cell, the ability of ceramide to physically alter membrane structure, formation, and fusion, rather than serving solely as a lipid secondary messenger, may severely compromise normal endocytic trafficking. In this review, we will discuss the potential pathological effects of abnormal sphingomyelin/ceramide metabolism on intracellular vesicular transport in relation to both amyloid accumulation in AD and various neurodegenerative diseases associated with lysosomal abnormalities.


Subject(s)
Ceramides/metabolism , Endosomes/metabolism , Lysosomes/metabolism , Neurodegenerative Diseases/metabolism , Sphingomyelins/metabolism , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Biological Transport , Cell Membrane/metabolism , Endocytosis/physiology , Humans , Neurodegenerative Diseases/pathology
7.
Brain Res Bull ; 59(6): 523-31, 2003 Feb 15.
Article in English | MEDLINE | ID: mdl-12576150

ABSTRACT

Impairment of endosomal/lysosomal functions are reported as some of the earliest changes in several age-related neurological disorders such as Alzheimer's disease. Dysregulation of the lysosomal system is also accompanied by the accumulation of age-associated pigments and several recent reports have indicated that this age-related lipofuscin accumulation can sensitize cells to oxidative stress and apoptotic cell death. In this study, we have established and evaluated an in vitro age-related pathology paradigm that models lipofuscin accumulation. Our model consists of the treatment of cultured primary mouse neurons with lysosomotropic detergents. We have observed that one of the earliest biochemical changes associated with lysosomotropic detergent-induced membrane instability is a loss of the endosomal/lysosomal proton gradient integrity, followed by an activation of sphingomyelin hydrolysis and ceramide accumulation within enlarged endosomal/lysosomal vesicles. In addition, we demonstrate that ceramide accumulation correlates with the activation of proximal procaspases-8 and -9 as well as distal caspase-3, prior to the appearance of cell death. Taken together, we propose that disturbances of the endosomal/lysosomal system, in addition to the activation of the sphingomyelinase hydrolysis cycle, play essential roles in the course of post-mitotic neuronal aging. The abnormal accumulation of undigested lipids and proteins within dysfunctional endosomal/lysosomal vesicle populations during the process of pathological aging may serve as triggers of the cell death programs that are associated with downstream neurodegeneration.


Subject(s)
Caspases/metabolism , Ceramides/metabolism , Endosomes/enzymology , Lysosomes/enzymology , Neurons/metabolism , Animals , Caspase Inhibitors , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Detergents/pharmacology , Endosomes/drug effects , Enzyme Inhibitors/pharmacology , Female , Intracellular Membranes/drug effects , Intracellular Membranes/enzymology , Lysosomes/drug effects , Mice , Neurons/cytology , Pregnancy , Second Messenger Systems/physiology
8.
Neuromolecular Med ; 1(1): 81-94, 2002.
Article in English | MEDLINE | ID: mdl-12025818

ABSTRACT

The amyloid beta-peptide (Abeta) is a 39-43 residue amphipathic peptide that is the major proteinaceous component of senile plaques that are characteristic of Alzheimer's disease (AD). To examine the contribution of the hydrophobic carboxyl-terminal domain on the aggregation, fibril formation, and neurotoxic activity, we have examined the effect of substituting the carboxyl-terminal residues 29-42 derived from two other type I transmembrane proteins: the beta-adrenergic and low-density lipoprotein (LDL) receptor. The chimeric peptides, Abeta1-28ADR29-42 and Abeta1-28LDL29-42, have the same high beta-sheet content as human Abeta1-42 in solution at pH 7.4 and display a conformation-dependent epitope that is associated with Abeta aggregates, indicating that these properties are largely independent of the carboxyl domain sequence. Previous studies have shown that the length of the carboxyl terminus is important for the formation of sodium dodecyl sulfate (SDS)-resistant oligomers. Abeta1-42 and the chimeric peptides co-assemble to form SDS-resistant, oligomeric mixed aggregates in all permutations, indicating that this interaction is not sequence specific. Upon assembly into insoluble aggregates, both chimeric peptides display an amorphous morphology rather than the regular 6-10 nm fibrils that are typical of human Abeta1-42. Abeta1-28ADR29-42 is equally toxic to primary rat hippocampal neurons as Abeta1-42, while Abeta1-28LDL29-42 is devoid of toxic activity. These results indicate that although beta-sheet conformation may be required for toxic activity, it is not sufficient and 6-10 nm fibril morphology is not an obligate requirement for neuronal toxicity.


Subject(s)
Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Peptide Fragments/chemistry , Alzheimer Disease/pathology , Amino Acid Sequence , Amyloid beta-Peptides/ultrastructure , Circular Dichroism , Epitopes/chemistry , Humans , Hydrogen-Ion Concentration , Molecular Sequence Data , Neurotoxins/chemistry , Protein Conformation , Protein Structure, Secondary , Recombinant Fusion Proteins/chemistry
9.
Nat Med ; 8(3): 289-93, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11875501

ABSTRACT

Prostaglandins (PGs), bioactive lipid molecules produced by cyclooxygenase enzymes (COX-1 and COX-2), have diverse biological activities, including growth-promoting actions on gastrointestinal mucosa. They are also implicated in the growth of colonic polyps and cancers. However, the precise mechanisms of these trophic actions of PGs remain unclear. As activation of the epidermal growth factor receptor (EGFR) triggers mitogenic signaling in gastrointestinal mucosa, and its expression is also upregulated in colonic cancers and most neoplasms, we investigated whether PGs transactivate EGFR. Here we provide evidence that prostaglandin E2 (PGE2) rapidly phosphorylates EGFR and triggers the extracellular signal-regulated kinase 2 (ERK2)--mitogenic signaling pathway in normal gastric epithelial (RGM1) and colon cancer (Caco-2, LoVo and HT-29) cell lines. Inactivation of EGFR kinase with selective inhibitors significantly reduces PGE2-induced ERK2 activation, c-fos mRNA expression and cell proliferation. Inhibition of matrix metalloproteinases (MMPs), transforming growth factor-alpha (TGF-alpha) or c-Src blocked PGE2-mediated EGFR transactivation and downstream signaling indicating that PGE2-induced EGFR transactivation involves signaling transduced via TGF-alpha, an EGFR ligand, likely released by c-Src-activated MMP(s). Our findings that PGE2 transactivates EGFR reveal a previously unknown mechanism by which PGE2 mediates trophic actions resulting in gastric and intestinal hypertrophy as well as growth of colonic polyps and cancers.


Subject(s)
Colonic Neoplasms/metabolism , Dinoprostone/metabolism , ErbB Receptors/metabolism , Gastric Mucosa/metabolism , MAP Kinase Signaling System/physiology , Transcriptional Activation/physiology , Animals , Cell Line , Dinoprostone/pharmacology , Enzyme Inhibitors/pharmacology , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Genes, src/physiology , Humans , Hypertrophy/pathology , Matrix Metalloproteinases/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Phosphorylation , Quinazolines/pharmacology , Rats , Rats, Sprague-Dawley , Tyrphostins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...